ROCHESTER — OptimizeRx Corp. (OTCQB:OPRX), the Rochester-based provider of digital health messaging for the pharmaceutical industry, has appointed Patrick Spangler and Bryan Archambault to its board of directors. Spangler will also serve as chair of the board’s newly formed audit committee.
Spangler replaces Dr. Jack Pinney, who has been appointed to serve as head of the company’s medical advisory board, which is now comprised of five physicians. Archambault will represent WPP plc, the British advertising and public relations company , which is a strategic investor in OptimizeRx, replacing board member Lynn O’Connor Vos in this role.
Vos, who left her position as CEO of WPP’s subsidiary, Grey Healthcare Group (GHG), to become CEO of the Muscular Dystrophy Association, will remain on OptimizeRx’s board as now an independent director. Following these appointments, the board of OptimizeRx will be comprised of six board members, with four serving independently.
“These appointments reflect our plans to scale our business and further enhance our product offerings, with WPP continuing to be an important strategic partner,” said William Febbo, OptimizeRx CEO.
OptimizeRx’s growing point-of-care network now reaches more than 50 percent of ambulatory health care providers in the U.S., making it the healthcare industry’s largest point-of-prescribe network. It delivers real-time access to financial assistance, education, and critical clinical information from pharmaceutical companies to health care providers.
Spangler presently serves as CFO of VigiLanz, a health care information firm, and as a member of the board of directors of Lifespace Communities. He brings to OptimizeRx more than 32 years of experience in the health care industry. He has helped lead high-performance, emerging growth firms, as well as large publicly traded companies. He has also served in the private equity sector successfully improving operational results with a broad array of portfolio companies.
Earlier, Spangler served as executive vice president and CFO of Healthland, an electronic health records company serving the critical access hospital market. He has also served as CFO at the point-of-care medical applications provider, Epocrates, that he helped bring public in 2011, and which was eventually acquired by Athena Health. Prior to Epocrates, he was CFO of the EV3, a vascular therapy developer that went public in 2005 and was acquired by Covidien, as well as CFO of the medical device manufacturer, Empi, which was acquired by Encore Medical.
Spangler previously served on the board of directors of Urologix, a provider of in-office minimally invasive medical products for the treatment of benign prostatic hyperplasia. He holds a Bachelor of Science in accounting and a Masters of Business Taxation from Carlson School of Management at the University of Minnesota, and an MBA from Booth School of Business at the University of Chicago.
Achambault serves as chief marketing officer at GHG Kansas City. He brings to the board of OptimizeRx a diverse background in the sales and customer-base marketing spanning more than 20 years. He has applied this experience to the brand and multichannel marketing strategies of clients in biopharma and animal health.
Vos currently serves as president and CEO of the Muscular Dystrophy Association, which fights muscular dystrophy and ALS through its funding of research, clinical care, support service, and education. Vos has a hands-on appreciation for patient care, and has considerable executive experience and expertise in the fields of pharmacology, medical and clinical education and digital marketing.
Prior to MDA, Vos was the CEO of GHG for nearly 23 years. Vos led GHG’s global expansion and diversification strategies, and within two years grew the company from a small, domestic industry player into an award-winning global enterprise with fully integrated, multi-channel offerings.
Pinney is a board-certified family physician with additional board certification in sports medicine. He is also an assistant clinical professor of family medicine at Michigan State University College of Human Medicine, as well as medical director of Wellsport at MidMichigan Health Medical Center.
Pinney is graduate of the Wayne State University School of Medicine and the Family Practice Residency Program at MidMichigan Regional Medical Center.
OptimizeRx provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers. The company’s cloud-based system supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and critical clinical information. The company’s network is comprised of leading EHR platforms like Allscripts, Amazing Charts and Quest, and provides more than half a million healthcare providers access to these benefits within their workflow at the point of care. For more information, visit www.optimizerx.com.